…another stock I have in my portfolio – this one already performing well – is Thrombogenics, a biopharmaceutical company focused on developing and commercialising innovative ophthalmic medicines (that’s the spiel), and based in Belgium. Earlier this year Thrombogenics announced that theirMicroplasmin Meets Primary Endpoint in Phase III Trial for the Non-SurgicalTreatment of Symptomatic Vitreomacular Adhesion (VMA) . In other words market their Microplasmin product has received the green light - and that’s why I am backing them. The shares are listed on the Eurolist by Euronext Brussels under the symbol THR and are currently trading (21 Sept 2012) at €30.11, which is 35% up on when I bought them almost a year ago. They’re worth backing in my view. Please note: The views and opinions in this post are my own and should not constitute advice to purchase the stocks quoted.
Building an Apple App used to cost a fortune – usually via an Elance contractor in India, the Ukraine or China. I did one this way, called iSmashit, and I haven’t got my investment back yet! Apple ? Then I had a crack at doing it myself: I already had an AppStore account (courtesy of iSmashit ) and so I got an Apple Developer Licence and downloaded Xcode onto to my Apple (you need Lion OS for it by the way). I made pretty good progress, largely due to the excellent courses at Lynda.com. But I still ain’t no Angry Birds builder! Bloggers with vastly more experience than me, such as JohnChow (in my view, simply the best), have recently recommended app building programmes such as bloapp , which create customised apps for bloggers. But now we can go the whole nine yards and build fully-fledged Apple Apps for ourselves, thereby adding to Apple’s existing half million live apps! You could use Conduit - basic but effective. You can do the same thing with M